{"id":6727,"date":"2023-02-08T11:05:00","date_gmt":"2023-02-08T11:05:00","guid":{"rendered":"https:\/\/nanexa.com\/mfn_news\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\/"},"modified":"2023-02-08T11:05:00","modified_gmt":"2023-02-08T11:05:00","slug":"nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\/","title":{"rendered":"Nanexa deltar p\u00e5 4th annual \u201cBeyond Medicines\u2019 Barriers Meeting\u201d, arrangerat av International Myeloma Foundation"},"content":{"rendered":"
\n

Nanexa \u00e4r inbjudna till och deltar som en av sponsorerna p\u00e5 4th annual \u201dBeyond Medicines\u2019 Barriers Meeting\u201d, arrangerat av International Myeloma Foundation (IMF) den 7-8 februari i Lugano, Schweiz.<\/strong><\/p>\n<\/div>\n

\n

P\u00e5 m\u00f6tet samlas patienter, patientf\u00f6retr\u00e4dare, forskare, v\u00e5rdpersonal, h\u00e4lsoekonomer, myndighetsf\u00f6retr\u00e4dare, myelomexperter och l\u00e4kemedelsbolag f\u00f6r att diskutera och initiera olika s\u00e4tt att optimera anv\u00e4ndandet av nya l\u00e4kemedel mot multipelt myelom.<\/p>\n

IMF \u00e4r v\u00e4rldens st\u00f6rsta patientorganisation med fokus specifikt p\u00e5 multipelt myelom och har mer \u00e4n 525\u00a0000 medlemmar i 140 l\u00e4nder. Organisationen jobbar f\u00f6r att f\u00f6rb\u00e4ttra livskvaliteten f\u00f6r myelompatienter och att arbeta f\u00f6r prevention och bot av sjukdomen.<\/p>\n

\u201dDet \u00e4r mycket viktigt f\u00f6r Nanexa som litet l\u00e4kemedelsbolag med klinisk utveckling av ett nytt l\u00e4kemedel mot multipelt myelom att f\u00e5 en m\u00f6jlighet att delta p\u00e5 ett internationellt m\u00f6te av det h\u00e4r slaget. Det ger oss ett tillf\u00e4lle att diskutera fr\u00e5gan kring myelompatienters f\u00f6ljsamhet av den l\u00e4kemedelsbehandling de f\u00e5r mot sin sjukdom med b\u00e5de patientorganisationen samt med de globala l\u00e4kemedelsbolagen som \u00e4r verksamma inom omr\u00e5det\u201d, s\u00e4ger Bengt Gustavsson, Director Clinical Development and Medical Affairs p\u00e5 Nanexa.<\/p>\n<\/div>\n

\n

F\u00f6r mer information kontakta:<\/strong><\/p>\n

\n

David Westberg \u2013 VD, Nanexa AB (publ)\u00a0
Telefon: 0709-42 83 03
E-post:\u00a0david.westberg@nanexa.se<\/a>
www.nanexa.com<\/a><\/p>\n

Erik Penser Bank \u00e4r bolagets Certified Adviser och n\u00e5s p\u00e5 08-463 83 00, e-post: certifiedadviser@penser.se<\/p>\n<\/div>\n

\n

Om Nanexa AB (publ)<\/strong><\/p>\n

\n

Nanexa \u00e4r ett l\u00e4kemedelsbolag som utvecklar injicerbara l\u00e4kemedel baserade p\u00e5 det patenterade och innovativa drug delivery-systemet PharmaShell\u00ae \u2013 ett system som m\u00f6jligg\u00f6r n\u00e4sta generations l\u00e5ngverkande injicerbara l\u00e4kemedel med h\u00f6g drug load, tillverkade med atomlagerprecision. Nanexa utvecklar egna produkter och har dessutom samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland Novo Nordisk och AstraZeneca.<\/p>\n

Nanexas aktie \u00e4r noterad p\u00e5 Nasdaq First North Growth Market i Stockholm (NANEXA).<\/p>\n<\/div>\n

\n

Bifogade filer<\/strong><\/p>\n

\n

Nanexa deltar p\u00e5 4th annual \u201cBeyond Medicines\u2019 Barriers Meeting\u201d, arrangerat av International Myeloma Foundation<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Nanexa \u00e4r inbjudna till och deltar som en av sponsorerna p\u00e5 4th annual \u201dBeyond Medicines\u2019 Barriers Meeting\u201d, arrangerat av International Myeloma Foundation (IMF) den 7-8 februari i Lugano, Schweiz.<\/p>\n","protected":false},"template":"","class_list":["post-6727","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nNanexa deltar p\u00e5 4th annual \u201cBeyond Medicines\u2019 Barriers Meeting\u201d, arrangerat av International Myeloma Foundation - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa deltar p\u00e5 4th annual \u201cBeyond Medicines\u2019 Barriers Meeting\u201d, arrangerat av International Myeloma Foundation - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa \u00e4r inbjudna till och deltar som en av sponsorerna p\u00e5 4th annual \u201dBeyond Medicines\u2019 Barriers Meeting\u201d, arrangerat av International Myeloma Foundation (IMF) den 7-8 februari i Lugano, Schweiz.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minuter\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\\\/\",\"name\":\"Nanexa deltar p\u00e5 4th annual \u201cBeyond Medicines\u2019 Barriers Meeting\u201d, arrangerat av International Myeloma Foundation - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2023-02-08T11:05:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa deltar p\u00e5 4th annual \u201cBeyond Medicines\u2019 Barriers Meeting\u201d, arrangerat av International Myeloma Foundation\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa deltar p\u00e5 4th annual \u201cBeyond Medicines\u2019 Barriers Meeting\u201d, arrangerat av International Myeloma Foundation - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa deltar p\u00e5 4th annual \u201cBeyond Medicines\u2019 Barriers Meeting\u201d, arrangerat av International Myeloma Foundation - Nanexa AB","og_description":"Nanexa \u00e4r inbjudna till och deltar som en av sponsorerna p\u00e5 4th annual \u201dBeyond Medicines\u2019 Barriers Meeting\u201d, arrangerat av International Myeloma Foundation (IMF) den 7-8 februari i Lugano, Schweiz.","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"2 minuter"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\/","name":"Nanexa deltar p\u00e5 4th annual \u201cBeyond Medicines\u2019 Barriers Meeting\u201d, arrangerat av International Myeloma Foundation - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2023-02-08T11:05:00+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-deltar-pa-4th-annual-beyond-medicines-barriers-meeting-arrangerat-av-international-myeloma-foundation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa deltar p\u00e5 4th annual \u201cBeyond Medicines\u2019 Barriers Meeting\u201d, arrangerat av International Myeloma Foundation"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/6727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=6727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}